Immunogenicity assay cut point determination using nonparametric tolerance limit.

Area of Science:

• Biopharmaceutical Development
• Analytical Chemistry
• Regulatory Science

Background:

• FDA guidance recommends specific cut points for immunogenicity assays to ensure a low false positive rate.
• Existing methods for determining these cut points often fail to address repeated measures or normality assumptions inherent in assay data.
• This can lead to inaccurate cut point estimates and unacceptable false positive rates.

Purpose of the Study:

• To develop and evaluate novel non-parametric methods for immunogenicity assay cut point determination.
• To address limitations of existing methods, specifically their handling of repeated measures and non-normal data.
• To provide a robust and reliable method for cut point calculation in immunogenicity assay validation.

Main Methods:

• Proposed two non-parametric statistical methods designed for repeated measure data structures.
• Did not assume normal distribution of the data, accommodating real-world assay variability.
• Conducted simulation studies to compare the performance of the proposed methods against existing approaches.

Main Results:

• One of the proposed non-parametric methods demonstrated superior performance compared to current methods.
• The preferred method achieved satisfactory coverage probability, even with moderate sample sizes.
• The method is simple, straightforward to implement, and provides reliable cut point estimates.

Conclusions:

• The developed non-parametric method is a preferred approach for determining cut points in immunogenicity assay development and validation.
• It effectively handles repeated measures and non-normal data, ensuring a more accurate false positive rate.
• This offers a significant improvement for biopharmaceutical regulatory submissions and drug safety.